Heartwarming stem cell donation from China to US witnesses relay of hope and bond
Liu Zhengchen (left) sits beside a stem cell donor, surnamed Li, as Li lies on a hospital bed while undergoing hematopoietic ...
EurekAlert!4 天
Borrowing nature’s blueprint: How scientists replicated bone marrow
Penn researchers have developed a platform that emulates human bone marrow’s native environment. This breakthrough addresses ...
Stem Cell Factor (SCF) Market: Forecast to Grow at a 11.4% CAGR, Driven by Recombinant ...
The Global Stem Cell Factor (SCF) Market was valued at USD 12900 Million in 2023 and is anticipated to reach USD Million by ...
C&EN6 天
How the bone marrow microbiome responds to immunotherapy
This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.
Too Old to Operate3 天
Prevalence and Management of Genital GVHD After Allogeneic HSCT
The following is a summary of “Genital graft versus host disease in women after allogeneic hematopoietic stem cell transplantation – a single center experience,” published in the January 2025 issue of ...
Researchers pinpoint keys to cell therapy response for leukemia
Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a ...
Targeted Oncology4 天
FDA Grants Orphan Drug Designation to MB-105 for R/R T-Cell Lymphoma
MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...
Taiwan News10 天
Beam Therapeutics to Encore Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle ...
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the company will encore data from the BEACON Phase 1/2 ...